Abstract
Neuromodulin (GAP-43), neurogranin (RC3), and PEP-19 are small acid-stable proteins that bind calcium-poor calmodulin through a loosely conserved IQ-motif. Even though these proteins have been known for many years, much about their function in cells is not understood. It has recently become appreciated that calmodulin activity in cells is tightly controlled and that pools of otherwise free calmodulin are sequestered so as to restrict its availability for activating calcium/calmodulin-dependent enzymes. Neuromodulin, neurogranin, and PEP-19 appear to be major participants in this type of regulation. One way in which they do this is by providing localized increases in the concentration of calmodulin in cells so that the maximal level of target activation is increased. Additionally, they can function as calmodulin antagonists by directly inhibiting the association of calcium/calmodulin with enzymes and other proteins. Although neuromodulin, neurogranin, and PEP-19 were early representatives of the small IQ-motif-containing protein family, newer examples have come to light that expand the number of cellular systems through which the IQ-peptide/calmodulin interaction could regulate biological processes including gene transcription. It is the purpose of this review to examine the behavior of neuromodulin, neurogranin, and PEP-19 in paradigms that include both in vitro and in situ systems in order to summarize possible biological consequences that are linked to the expression of this type of protein. The use of protein:protein interaction chromatography is also examined in the recovery of a new calmodulin-binding peptide, CAP-19 (ratMBF1). Consistent with earlier predictions, at least one function of small IQ-motif proteins appears to be that they lessen the extent to which calcium-calmodulin-dependent enzymes become or stay activated. It also appears that these polypeptides can function to selectively inhibit activation of intracellular targets by some agonists while simultaneously permitting activation of these same targets by other agonists. Much of the mechanism for how this occurs is unknown, and possible explanations are examined. One of the biological consequences for a cell that expresses a calmodulin-regulatory protein could be an increased resistance to calcium-mediated toxicity. This possibility is examined for cells expressing PEP-19 and both anatomical and cell-biological data is described. The study of IQ-motif-containing small proteins has stimulated considerable thought as to how calcium signaling is refined in neurons. Current evidence suggests that signaling through calmodulin is not a fulminating and homogenous process but a spatially limited and highly regulated one. Data from studies on neuromodulin, neurogranin, and PEP-19 suggest that they play an important role in establishing some of the processes by which this regulation is accomplished.
Similar content being viewed by others
References
Ghosh A. and Greenberg M. E. (1995) Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268, 239–247.
Deisseroth K., Heis E. K., and Tsien R. W. (1998) Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392, 198–202.
De Koninck P. and Schulman H. (1998) Sensitivity of CaM Kinase II to the frequency of Ca2+ oscillations. Science 279, 227–230.
Trump B. F. and Berezesky I. K. (1992) The role of Ca2+ in cell injury, necrosis and apoptosis. Curr. Opin. Biol. 4, 227–232.
Vendrell M., Curran T., and Morgan J. I. (1993) Glutamate, immediate-early genes, and cell death in the nervous system. Ann. NY Acad. Sci. 679, 132–141.
Curran T. and Morgan J. (1987) Memories of fos. Bioessays 7, 255–258.
Bito H., Deisseroth K., and Tsien R. W. (1996) CREB phosphorylation and dephosphorylation: a Ca2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87, 1203–1214.
Impey S., Obrietan K., Wong S. T., Poser S., Yano S., Wayman G., et al. (1998) Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 21, 869–883.
Kakiuchi S., Yasuda S., Yamazaki R., Teshima Y., Kanda K., Kakiuchi R., and Sobue K. (1982) Quantitative determinations of calmodulin in the supernatant and particulate fractions of mammalian tissues. J. Biochem. 92, 1041–1048.
Klee C. B. and Vanaman T. C. (1982) Calmodulin. Adv. Protein Chemi. 35, 213–321.
Liu Y. and Storm D. R. (1990) Regulation of free calmodulin levels by neuromodulin: neuron growth and regeneration. Trends Pharmacol. Sci. 11, 107–111.
McIlroy B. K., Walters J. D., Blackshear P. J., and Johnson J. D. (1991) Phosphorylation-dependent binding of a synthetic MARCKS peptide to calmodulin. J. Biol. Chem. 266, 4959–4964.
Gerendasy D. D., Herron S. R., Wong K. K., Watson J. B., and Sutcliffe J. G. (1994) Mutational and biophysical studies suggest RC3/neurogranin regulates calmodulin availability. J. Biol. Chem. 269, 22,420–22,426.
Porter J. A., Yu M., Doberstein S. K., Pollard T. D., and Montell C. (1993) Dependence of calmodulin localization in the retina on the NINAC unconventional myosin. Science 262, 1038–1042.
Sacks D. B., Mazus B., and Joyal J. L. (1995) The activity of calmodulin is altered by phosphorylation: modulation of calmodulin function by the site of phosphate incorporation. Biochem. J. 312, 197–204.
Quadroni M., L’Hostis E. L., Corti C., Myagkikh I., Durussel I., Cox J., James P., and Carafoli E. (1998) Phosphorylation of calmodulin alters its potency as an activator of target enzymes. Biochemistry 37, 6523–6532.
Persechini A. and Cronk B. (1999) The relationship between the free concentrations of Ca2+ and Ca2+-calmodulin in intact cells. J. Biol. Chem. 274, 6827–6830.
Skene J. H. S. (1989) Axonal growth-associated proteins. Ann. Rev. Neurosci. 12, 127–156.
Coggins P. J. and Zwiers H. (1991) B-50 (GAP-43): Biochemistry and functional neurochemistry of a neuron-specific phosphoprotein. J. Neurochem. 56, 1095–1106.
Gerendasy D. D. and Sutcliffe J. G. (1997) RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes. Mol. Neurobiol. 15, 131–163.
Ziai R., Pan Y.-C. E., Hulmes J. D., Sangameswaran L., and Morgan J. I. (1986) Isolation, sequence, and developmental profile of a brain-specific polypeptide, PEP-19. Proc. Natl. Acad. Sci. USA 83, 8420–8423.
Berrebi A. S., Oberdick J., Sangameswaran L., Christakos S., Morgan J. I., and Mugnaini E. (1991) Cerebellar Purkinje cell markers are expressed in retinal bipolar neurons. J. Comp. Neurol. 308, 630–649.
Utal A. K., Stopka A. L., Roy M., and Coleman P. D. (1998) PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington’s disease. Neuroscience 86, 1055–1063.
Berrebi A. S. and Mugnaini E. (1991) Distribution and targets of the cartwheel cell axon in the dorsal cochlear nucleus of the guinea pig. Anat. Embryol. 183, 427–454.
Berrebi A. S. and Spirou G. A. (1998) PEP-19 immunoreactivity in the cochlear nucleus and superior olive of the cat. Neuroscience 83, 535–554.
Sangameswaran L., Hempstead J., and Morgan J. I. (1989) Molecular cloning of a neuron-specific transcript and its regulation during normal and aberrant cerebellar development. Proc. Natl. Acad. Sci. USA 86, 5651–5655.
Chikawa H., Morgan J. I., and Sugimoto T. (1999) Peptide 19 in the dorsal root ganglion and the mesencephalic trigeminal tract nucleus of the adult rat. Brain Res. 821, 231–235.
Ichikawa H. and Sugimoto T. (1999) Peptide 19-immunoreactive primary sensory neurons in the rat trigeminal ganglion. Brain Res. 846, 274–279.
Sangameswaran L. and Morgan J. I. (1993) Structure and regulation of the gene encoding the neuron-specific protein PEP-19. Mol. Brain Res. 19, 62–68.
West M. J., Coleman P. D., Flood D. G., and Troncoso J. C. (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s disease. Lancet 344, 769–772.
Slemmon J. R., Hughes C. M., Campbell G. A., and Flood D. G. (1994) Increased levels of hemoglobin-derived ad other peptides in Alzheimer’s disease cerebellum. J. Neurosci. 14, 2225–2235.
Martin S. J., Green D. R., and Cotter T. G. (1994) Dicing with death: dissecting the components of the apoptosis machinery. Trends Biol. Sci. 19, 26–30.
Dawson T. M., Hung K., Dawson V. L., Steiner J. P., and Snyder S. H. (1995) Neuroprotective effects of gangliosides may involve inhibition o nitric oxide synthase. Ann. Neurol. 37, 115–118.
Bao J., Sharp A. H., Wagster M. V., Becher M., Schilling G., Ross C. A., et al. (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci. USA 93, 5037–5042.
Smith M. L., Johanson R. A., Rogers K. E., Coleman P. D., and Slemmon J. R. (1998) Identification of a neuronal calmodulin-binding peptide, CAP-19, containing an IQ motif. Mol. Brain Res. 62, 12–24.
Slemmon J. R. and Martzen M. R. (1994) Neuromodulin (GAP-43) can regulate a calmodulindependent target in vitro. Biochemistry 33, 5653–5660.
Martzen M. R. and Slemmon J. R. (1995) The dendritic peptide neurogranin can regulate a calmodulin-dependent target. J. Neurochem. 64, 92–100.
Mooseker M. S. (1992) Primary structure and cellular localization of chicken brain myosin-V (p190), an unconventional myosin with calmodulin light chains. J. Cell Biol. 119, 1541–1557.
Slemmon J. R., Morgan J. I., Fullerton S. M., Danho W., Hilbush B. S., and Wengenack T. M. (1996) Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J. Biol. Chem. 271, 15,911–15,971.
Apel E. D., Byford M. F., Au D., Walsh K. A., and Storm D. R. (1990) Identification of the protein kinase C phosphorylation site in neuromodulin. Biochemistry 29, 2330–2335.
Baudier J., Deloulme J. C., Dorsselaer A. V., Black D., and Matthes H. W. D. (1991) Purification and characterization of a brain-specific protein kinase C substrate, neurogranin (p17). J. Biol. Chem. 266, 229–237.
Alexander K. A., Cimler B. M., Meier K. E., and Storm D. R. (1987) Regulation of calmodulin binding to P57. J. Biol. Chem. 262, 6108–6113.
Liu Y. and Storm D. R. (1989) Dephosphorylation of neuromodulin by calcineurin. J. Biol. Chem. 264, 12,800–12,804.
Skene J. H. P. and Virág I. (1989) Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43. J. Cell Biol. 108, 613–624.
Zuber M. X., Goodman D. W., Karns L. R., and Fishman M. C. (1989) The neuronal-associated protein GAP-43 induces filopodia in non-neuronal cells. Science 244, 1193–1195.
Liu Y., Chapman E. R., and Storm D. R. (1991) Targeting of neuromodulin (GAP-43) fusion proteins to growth cones in cultured rat embryonic neurons. Neuron 6, 411–420.
Sudo Y., Valenzuela D., Beck-Sickinger A. G., Fishman M. C., and Strittmatter S. M. (1992) Palmitoylation alters protein activity: blockade of Go stimulation by GAP-43. EMBO J. 11, 2095–2102.
Strittmatter S. M., Cannon S. C., Ross E. M., Higashijima T., and Fishman M. C. (1993) GAP-43 augments G protein-coupled receptor transduction in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. USA 90, 5327–5331.
Egberongbe Y. I., Gentleman S. M., Falkai P., Bogerts B., Polak J. M., and Roberts G. W. (1994) The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59, 561–578.
Saxon D. W. and Beitz A. J. (1994) Cerebellar injury induces NOS in Purkinje cells in cerebellar afferent neurons. NeuroReport 5, 809–812.
Bredt D. S. and Snyder S. H. (1990) Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682–685.
Johanson R. A., Sarau H. M., Foley J. J., and Slemmon J. R. (2000) Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II in situ. J. Neurosci. 20, 2860–2866.
Quadroni M., James P., and Carafoli E. (1994) Isolation of phosphorylated calmodulin from rat liver and identification of the in vivo phosphorylation sites. J. Biol. Chem. 269, 16,116–16,122.
Benguría A., Soriano M., Joyal J. L., Sacks D. B., and Villalobo A. (1995) Phosphorylation of calmodulin by plasma-membrane-associated protein kinase(s). Eur. J. Biochem. 234, 50–58.
Joyal J. L., Crimmins D. L., Thoma R. S., and Sacks D. B. (1996) Identification of insulin-stimulated phosphorylation sites on calmodulin. Biochemistry 35, 6267–6275.
De Fructos T., Martín-Nieto J., and Villalobo A. (1997) Phosphorylation of calmodulin by permeabilized fibroblasts overexpressing the human epidermal growth factor receptor. Biol. Chem. 378, 31–37.
Erhardt J. A., Johanson R. A., Slemmon J. R., and Wang X. (2000) Expression of PEP-19 inhibits apoptosis in PC12 cells. NeuroReport 11, 3719–3723.
Kruman I., Guo Q., and Mattson M. P. (1998) Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51, 293–308.
Prehn J. H. M., Jordan J., Ghadge G. D., Preis E., Galindo M. F., and Roos R. P., et al. (1997) Calcium and reactive oxygen species in staurosporine-induced neuronal apoptosis. J. Neurochem. 68, 1679–1685.
Takemaru K-I., Li F-Q., Ueda H., and Hirose S. (1997) Multiple bridging factor 1 (MBF1) is an evolutionarily conserved transciptional coactivator that connects a regulatory factor TATA element-binding protein. Proc. Natl. Acad. Sci. USA 94, 7251–7256.
Kabe Y., Goto M., Shima D., Imai T., Wada T., Morohashi K-i., Shirakawa M., Hirose S., and Handa H. (1999) The role of human MBF1 as a transcriptional coactivator. J. Biol. Chem. 274, 34,196–34,202.
Mariotti M., De Benedictis L., Avon E., and Maier J. A. M. (2000) Interaction between endothelial differentiation-related factor-1 and calmodulin in vitro and in vivo. J. Biol. Chem. 275, 24,047–24,051.
Dragon I., Mariotti M., Consalez G. G., Soria M. R., and Maier J. A. M. (1998) EDF-1, a novel gene product down-regulated in human endothelial cell differentiation. J. Biol. Chem. 273, 31,119–31,124.
Klee C. B. (1991) Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin. Neurochem. Res. 16, 1059–1065.
Rich R. C. and Schulman H. (1998) Substrate-directed function of calmodulin in autophosphorylation of Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 273, 28,424–28,429.
Meyer T., Hanson P. I., Stryer L., and Schulman H. (1992) Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 256, 1199–1202.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Slemmon, J.R., Feng, B. & Erhardt, J.A. Small proteins that modulate calmodulin-dependent signal transduction. Mol Neurobiol 22, 99–113 (2000). https://doi.org/10.1385/MN:22:1-3:099
Issue Date:
DOI: https://doi.org/10.1385/MN:22:1-3:099